Literature DB >> 3026213

Hepatitis A virus in stool during clinical relapse.

M H Sjogren, H Tanno, O Fay, S Sileoni, B D Cohen, D S Burke, R J Feighny.   

Abstract

Among 256 patients with acute hepatitis A, 17 (6.6%) had a relapse of the disease between 30 and 90 days after the primary episode. We studied 7 of these patients. Serologic testing showed mean alanine aminotransferase levels of 1668 IU/L during the acute stage, 107 IU/L during the early convalescence, and 1027 IU/L during the relapse. Tests for IgM antibody against hepatitis A virus were positive in the 7 patients at the onset of disease, with decreasing levels in 3 of the 4 patients tested during the evolution of the illness. Stools collected during the relapse phase showed hepatitis A virus by immune electron microscopy, radioimmunoassay, and molecular hybridization using a 32P-labeled cDNA-hepatitis A virus probe. Stools collected from 4 of these patients 6 to 12 months after the onset of disease were negative for the virus. The finding of hepatitis A virus in the stool of these patients during the relapse phase strongly implicates hepatitis A virus as the causative agent of the clinical relapse.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3026213     DOI: 10.7326/0003-4819-106-2-221

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  21 in total

1.  Detection of hepatitis A virus by extraction of viral RNA and molecular hybridization.

Authors:  J R Ticehurst; S M Feinstone; T Chestnut; N C Tassopoulos; H Popper; R H Purcell
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

Review 2.  Diagnosis of hepatitis a virus infection: a molecular approach.

Authors:  Omana V Nainan; Guoliang Xia; Gilberto Vaughan; Harold S Margolis
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 3.  Hepatology.

Authors:  P M Harrison; J Y Lau; R Williams
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

Review 4.  Viral hepatitis.

Authors:  J Y Lau; G J Alexander; A Alberti
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 5.  Adaptive Immune Responses in Hepatitis A Virus and Hepatitis E Virus Infections.

Authors:  Christopher M Walker
Journal:  Cold Spring Harb Perspect Med       Date:  2019-09-03       Impact factor: 6.915

6.  Detection of hepatitis A virus by hybridization with single-stranded RNA probes.

Authors:  X Jiang; M K Estes; T G Metcalf
Journal:  Appl Environ Microbiol       Date:  1987-10       Impact factor: 4.792

7.  Virological course of hepatitis A virus as determined by real time RT-PCR: Correlation with biochemical, immunological and genotypic profiles.

Authors:  Zahid Hussain; Bhudev C Das; Syed A Husain; Sunil K Polipalli; Tanzeel Ahmed; Nargis Begum; Subhash Medhi; Alice Verghese; Mohammad Raish; Apiradee Theamboonlers; Yong Poovorawan; Premashis Kar
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

8.  Relapsing hepatitis in a child, associated with isolation of hepatitis A virus antigen from the liver.

Authors:  J N van den Anker; R N Sukhai; A M Dumas
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

Review 9.  New hepatitis A vaccines and their role in prevention.

Authors:  D B Strader; L B Seeff
Journal:  Drugs       Date:  1996-03       Impact factor: 9.546

Review 10.  Viral hepatitis.

Authors:  G V Gregorio; G Mieli-Vergani; A P Mowat
Journal:  Arch Dis Child       Date:  1994-04       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.